The Effect of Glaucoma on the Quality of Patient’s Life

1. Chun Y, Lee DI, Kwon J, et al. Comparison of impact of monocular and integrated binocular visual fields on vision- related quality of life. J Glaucoma. 2017;26:283–291.10.1097/IJG.000000000000062328079653Search in Google Scholar

2. van Gestel A, Webers CA, Beckers HJ, et al. The relationship between visual field loss in glaucoma and health-related quality-of-life. Eye (Lond). 2010;24:1759–1769.10.1038/eye.2010.13321057519Search in Google Scholar

3. Asaoka R, Crabb DP, Yamashita T, et al. Patients have two eyes!: binocular versus better eye visual field indices. Invest Ophthalmol Vis Sci. 2011;52:7007–7011.10.1167/iovs.11-764321810985Search in Google Scholar

4. Lisboa R, Chun YS, Zangwill LM, et al. Association between rates of binocular visual field loss and vision-related quality of life in patients with glaucoma. JAMA Ophthalmol. 2013;131:486–494.10.1001/jamaophthalmol.2013.2602380426423450425Search in Google Scholar

5. Cheng HC, Guo CY, Chen MJ, et al. Patient-reported vision- related quality of life differences between superior and inferior hemifield visual field defects in primary open-angle glaucoma. JAMA Ophthalmol. 2015;133:269–275.10.1001/jamaophthalmol.2014.490825429608Search in Google Scholar

6. Quaranta L, Riva I, Gerardi C, et al. Quality of life in glaucoma: a review of the literature. Adv Ther. 2016;33:959–981.10.1007/s12325-016-0333-6492085127138604Search in Google Scholar

7. Murata H, Hirasawa H, Aoyama Y, et al. Identifying areas of the visual field important for quality of life in patients with glaucoma. PLoS One. 2013;8:e58695.10.1371/journal.pone.0058695359281423520528Search in Google Scholar

8. Kwon M, Huisingh C, Rhodes LA, et al. Association between glaucoma and at-fault motor vehicle collision involvement among older drivers: a population-based study. Ophthalmology. 2016;123:109–116.10.1016/j.ophtha.2015.08.043469530326459997Search in Google Scholar

9. Diniz-Filho A, Boer ER, Elhosseiny A, et al. Glaucoma and driving risk under simulated fog conditions. Transl Vis Sci Technol. 2016;5:15.10.1167/tvst.5.6.15515644527980878Search in Google Scholar

10. Kubler TC, Kasneci E, Rosenstiel W, et al. Driving with glaucoma: task performance and gaze movements. Optom Vis Sci. 2015;92:1037–1046.10.1097/OPX.000000000000070226501733Search in Google Scholar

11. van Landingham SW, Hochberg C, Massof RW, et al. Driving patterns in older adults with glaucoma. BMC Ophthalmol. 2013;13:4.10.1186/1471-2415-13-4Search in Google Scholar

12. Nguyen AM, van Landingham SW, Massof RW, et al. Reading ability and reading engagement in older adults with glaucoma. Invest Ophthalmol Vis Sci. 2014;55:5284–’35290.10.1167/iovs.14-14138Search in Google Scholar

13. Yang Y, Trope GE, Buys YM, et al. Glaucoma severity and participation in diverse social roles: does visual field loss matter? J Glaucoma. 2016;25:e697–e703.10.1097/IJG.0000000000000353Search in Google Scholar

14. Janz NK,Wren PA, Lichter PR, et al. Quality of life in newly diagnosed glaucoma patients: the Collaborative Initial Glaucoma Treatment Study. Ophthalmology. 2001;108:887–897 discussion 898.10.1016/S0161-6420(00)00624-2Search in Google Scholar

15. Ramli N, Supramaniam G, Samsudin A, et al. Ocular surface disease in glaucoma: effect of polypharmacy and preservatives. Optom Vis Sci. 2015;92:e222–e226.10.1097/OPX.000000000000054225730335Search in Google Scholar

16. Pouyeh B, Viteri E, FeuerW, et al. Impact of ocular surface symptoms on quality of life in a United States veterans affairs population. Am J Ophthalmol. 2012;153:1061–1066. e3.10.1016/j.ajo.2011.11.03022330309Search in Google Scholar

17. Rossi GC, Tinelli C, Pasinetti GM, et al. Dry eye syndrome- related quality of life in glaucoma patients. Eur J Ophthalmol. 2009;19:572–579.10.1177/11206721090190040919551671Search in Google Scholar

18. Cvenkel B, Stunf S, Srebotnik K, et al. Symptoms and signs of ocular surface disease related to topical medication in patients with glaucoma. Clin Ophthalmol. 2015;9: 625–631.10.2147/OPTH.S81247439951825914521Search in Google Scholar

19. Perez-Bartolome F, Martinez-de-la-Casa JM, Arriola- Villalobos P, et al. Ocular surface disease in patients under topical treatment for glaucoma. Eur J Ophthalmol. 2017;27: 694–704.10.5301/ejo.500097728497458Search in Google Scholar

20. Terai N, Muller-Holz M, Spoerl E, et al. Short-term effect of topical antiglaucoma medication on tear-film stability, tear secretion, and corneal sensitivity in healthy subjects. Clin Ophthalmol. 2011;5:517–525.10.2147/OPTH.S18849309030821573041Search in Google Scholar

21. Anwar Z, Wellik SR, Galor A. Glaucoma therapy and ocular surface disease: current literature and recommendations. Curr Opin Ophthalmol. 2013;24:136–143.10.1097/ICU.0b013e32835c8abaSearch in Google Scholar

22. Tsai JC. A comprehensive perspective on patient adherence to topical glaucoma therapy. Ophthalmology. 2009;116 (suppl):S30–S36.10.1016/j.ophtha.2009.06.024Search in Google Scholar

23. Janz NK, Wren PA, Lichter PR, et al. The Collaborative Initial Glaucoma Treatment Study: interim quality of life findings after initial medical or surgical treatment of glaucoma. Ophthalmology. 2001;108:1954–1965.10.1016/S0161-6420(01)00874-0Search in Google Scholar

24. J Ophthalmol. 2017:1–7. King AJ, Fernie G, Azuara- Blanco A, et al. Treatment of Advanced Glaucoma Study: a multicentre randomised controlled trial comparing primary medical treatment with primary trabeculectomy for people with newly diagnosed advanced glaucoma-study protocol. Br.Search in Google Scholar

25. Zimmerman T, Karunaratne N, Fechtner R. Glaucoma: outcomeology (part I, II). J Glaucoma. 1996;5:151–155.10.1097/00061198-199606000-00001Search in Google Scholar

26. Spaeth G, Walt J, Keener J. Evaluation of quality of life for patients with glaucoma. Am J Ophthalmol. 2006;141 (suppl):S3–S14.10.1016/j.ajo.2005.07.075Search in Google Scholar

27. Wilson MR, Coleman AL, Yu F, et al. Functional status and well-being in patients with glaucoma as measured by the Medical Outcomes Study Short Form-36 questionnaire. Ophthalmology. 1998;105:2112–2116.10.1016/S0161-6420(98)91135-6Search in Google Scholar

28. Aspinall PA, Johnson ZK, Azuara-Blanco A, et al. Evaluation of quality of life and priorities of patients with glaucoma. Invest Ophthalmol Vis Sci. 2008;49:1907–1915.10.1167/iovs.07-055918436824Search in Google Scholar

29. Khanna CL, Leske DA, Holmes JM. Factors associated with health-related quality of life in medically and surgically treated patients with glaucoma. JAMA Ophthalmol. 2018.10.1001/jamaophthalmol.2018.0012587684729470573Search in Google Scholar

30. Nutheti R, Shmanna BR, Nirmalan PK, et al. Impact of impaired vision and eye disease on quality of life in Andhra Pradesh. Invest Ophthalmol Vis Sci. 2006;47: 4742–4748.10.1167/iovs.06-002017065482Search in Google Scholar

31. Peters D, Heijl A, Brenner L, et al. Visual impairment and vision-related quality of life in the Early Manifest Glaucoma Trial after 20 years of follow-up. Acta Ophthalmol. 2015;93:745–752.10.1111/aos.12839501420826382936Search in Google Scholar

32. Goldberg I, Clement CI, Chiang TH, et al. Assessing quality of life with glaucoma using the Glaucoma Quality of Life-15 (GQL-15) questionairre. J Glaucoma. 2009;18: 6–12.10.1097/IJG.0b013e3181752c8319142128Search in Google Scholar

33. Day DG, Sharpe Ed, Atkinson MJ, et al. The clinical validity of the treatment satisfaction survey for intraocular pressure in ocular hypertensive and glaucoma patients. Eye (London). 2006;20:583–590.10.1038/sj.eye.670193215933751Search in Google Scholar

34. Jampel HD, Frick KD, Janz NK, et al. Depression and mood indicators in newly diagnosed glaucoma patients. Am J Ophthalmol. 2007;144:238–244.10.1016/j.ajo.2007.04.04817560843Search in Google Scholar

35. Mabuchi F, Yoshimura K, Kashiwagi K, et al. High prevalence of anxiety and depression in patients with primary opan-angle glaucoma. J Glaucoma. 2008;17: 552–557.10.1097/IJG.0b013e31816299d418854732Search in Google Scholar

36. Tastan S, Iyigun E, Bayer A, et al. Anxiety, depression, and quality of life in Turkish patients with glaucoma. Psychol Rep. 2010;106:343–357.10.2466/pr0.106.2.343-357Search in Google Scholar

37. Zhou C, Qian S, Wu P, et al. Anxiety and depression in Chinese patients with glaucoma: sociodemographic, clinical, and self-reported correlates. J Psychosom Res. 2013;75:72–82.10.1016/j.jpsychores.2013.03.00523751243Search in Google Scholar

38. Mabuchi F, Yoshimura K, Kashiwagi K, et al. Risk factors for anxiety and depression in patients with glaucoma. Br J Ophthalmol. 2012;96:821–825.10.1136/bjophthalmol-2011-30091022353697Search in Google Scholar

39. Skalicky S, Goldberg I. Depression and quality of life in patients with glaucoma: a cross-sectional analysis using the Geriatric Depression Scale-15, Assessment of Function Related to Vision, and the Glaucoma Quality of Life-15. J Glaucoma. 2008;17: 546–5.10.1097/IJG.0b013e318163bdd118854731Search in Google Scholar

40. Stryker JE, Beck AD, Primo SA, et al. An exploratory study of factors influencing glaucoma treatment adherence. J Glaucoma. 2010;19:66–72.10.1097/IJG.0b013e31819c4679280819720075676Search in Google Scholar

41. Yochim BP, Mueller AE, Kane KD, et al. Prevalence of cognitive impairment, depression, and anxiety symptoms among older adults with glaucoma. J Glaucoma. 2012;21:250–254.10.1097/IJG.0b013e3182071b7e21336151Search in Google Scholar